Lakefront Biotherapeutics NV

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Goodwill $69.8m $69.6m $70.0m
Intangible Assets Other Than Goodwill $1.0m $2.5m $3.6m $24.9m $67.6m $60.1m $146.4m $127.9m $164.9m $848k
Additional Financial Items
Current Tax Liabilities Current $1.2m
Deferred Tax Assets $2.0m $2.0m $2.5m $4.2m $4.5m $4.0m $1.4m $1.1m $1.5m $195k
Issued Capital $223.9m $233.4m $236.5m $287.3m $291.3m $292.1m $293.6m $293.9m $293.9m $293.9m
Trade And Other Current Payables $31.3m $47.1m $68.9m $143.4m $172.4m $137.4m $148.7m $135.2m $98.9m $104.6m
Trade And Other Current Receivables $9.7m $28.0m $18.6m $54.0m $148.4m $111.3m $40.4m $28.4m $47.5m $20.7m
Trade And Other Payables $31.2m $47.1m $68.0m $142.5m $171.3m $134.3m $133.3m $134.7m $97.8m $32.6m
Unused Tax Losses For Which No Deferred Tax Asset Recognised $385.0m $567.0m $688.7m $862.0m $843.2m
Total Assets $1.1b $1.3b $1.4b $6.1b $5.7b $5.2b $4.7b $4.4b $4.1b $3.4b
LIABILITIES AND EQUITY
Deferred Tax Liabilities $20.1m $23.6m $20.7m
Deferred Tax Liability Asset ($18.8m) $1.1m
Increase Decrease Through Business Combinations Deferred Tax Liability Asset ($23.3m)
Increase Decrease Through Net Exchange Differences Deferred Tax Liability Asset $17k ($4k)
Total Liabilities $324.6m $274.3m $225.2m $3.2b $3.0b $2.5b $2.2b $1.6b $1.2b $170.7m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.